81 completed, 63 recruiting, 45 unknown, 29 active not recruiting. 151 Phase 2, 59 Phase 1, 29 Phase 3, 21 Not applicable, 3 Early Phase 1.
Follow Gastric Adenocarcinoma: new trials by email Literature Review of Gastric Adenocarcinoma trials Research Report on Gastric Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ACC-1898 in Adult Participants With Advanced Solid Tumors ACC-1898 - Hepatocellular Carcinoma, Renal Cell Carcinoma | Phase 1 | Not yet recruiting | AccSalus Biosciences, Inc. | 40 | 2027-01-01 | 2026-10-28 |
| Lymph Node Metastasis Pattern After Neoadjuvant Chemoimmunotherapy in LAGC Neoadjuvant SOX chemotherapy combined with PD-1 inhibitor - Stomach Neoplasms, Gastric Cancer (Diagnosis) | Not yet recruiting | Hainan General Hospital | 103 | 2027-01-01 | 2026-10-28 | |
| Magnetic Sentinel Lymph Node Mapping in Gastric Cancer Gastrectomy, Indocyanine Green, Iron Conjugated Polymers in Saline Suspension - Gastric Adenocarcinoma | Phase 1 | Not yet recruiting | M.D. Anderson Cancer Center | 20 | 2026-12-31 | 2026-08-14 |
| Pathological Response to Perioperative FLOT in Gastric Adenocarcinoma FLOT Chemotherapy - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Fundación Santa Fe de Bogota | 90 | 2026-10-01 | 2026-10-05 | |
| Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer APA program - Breast Cancer, Colorectal Cancer | Not applicable | Recruiting | Centre Antoine Lacassagne | 98 | 2026-09-15 | 2026-09-15 |
| Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma RP2, 5-Fluorouracil, Leucovorin - Gastric Adenocarcinoma, Esophageal Adenocarcinoma | Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 34 | 2026-09-01 | 2026-06-05 |
| Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer Laparoscopic Gastrectomy, Open Gastrectomy - Gastric Cancer, Gastric Adenocarcinoma | Not yet recruiting | Kocaeli City Hospital | 328 | 2026-09-01 | 2026-09-03 | |
| Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma (Siewert II-III) | Not yet recruiting | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 250 | 2026-09-01 | 2026-07-09 | |
| ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR Tumor-Informed ctDNA-MRD Monitoring, Clinician-Selected Standard-of-Care Postoperative Treatment - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 150 | 2026-09-01 | 2026-09-02 | |
| GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer Neoadjuvant chemotherapy, Olanzapine - Gastric Adenocarcinoma, Gastric Cancer | Phase 2 | Not yet recruiting | University of Illinois at Chicago | 26 | 2026-09-01 | 2026-08-21 |
| Silent Evaluation of DeepTRG for Assessing Tumor Response After Preoperative Treatment in Stomach and Gastroesophageal Junction Cancer AI-Based Digital Pathology Assessment of Treatment Response (DeepTRG) - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Recruiting | Qun Zhao | 200 | 2026-09-01 | 2026-09-30 | |
| Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma Sacituzumab Tirumotecan + Tagitanlimab - ESCC, Gastric Adenocarcinoma | Phase 2 | Not yet recruiting | Sun Yat-sen University | 75 | 2026-08-31 | 2026-07-14 |
| Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma Retlirafusp Alfa, Oxaliplatin, Capecitabine - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Not yet recruiting | Tang-Du Hospital | 21 | 2026-08-30 | 2026-07-17 |
| Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction Proximal gastrectomy with double-tract reconstruction - Gastric Adenocarcinoma, Adenocarcinoma of the Esophagogastric Junction | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 250 | 2026-08-15 | 2026-09-02 | |
| Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer Image-Guided Retrieval Specimen Platform, Traditional Palpation-Based Sentinel Lymph Node Retrieval - Early Gastric Cancer, Gastric Adenocarcinoma | Not applicable | Recruiting | Beijing Friendship Hospital | 36 | 2026-08-14 | 2026-09-22 |
| Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas Denikitug, Nivolumab, Ramucirumab - HER2-negative, Gastroesophageal Junction | Phase 2 | Recruiting | Gilead Sciences | 120 | 2026-08-07 | 2026-09-21 |
| A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India Gastric Adenocarcinoma, Early Gastric Cancer | Recruiting | Asian Institute of Gastroenterology, India | 4000 | 2026-08-01 | 2026-08-31 | |
| Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Sacituzumab Tirumotecan + Fruquintinib - Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 45 | 2026-07-31 | 2026-07-09 |
| A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer ASP2138, Pembrolizumab, Oxaliplatin - Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 3 | Recruiting | Astellas Pharma Global Development, Inc. | 570 | 2026-07-28 | 2026-10-22 |
| Breath Research Narrow Validation for Gastrointestinal Cancer Detection Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma | Recruiting | Imperial College London | 1000 | 2026-07-26 | 2026-10-22 |
Showing 20 of 287. Sign in to see all of them.
Stomach Neoplasms (99) · Adenocarcinoma Of Esophagus (46) · Esophageal Neoplasms (25) · Carcinoma, Non-Small-Cell Lung (20) · Squamous Cell Carcinoma of Head and Neck (18) · Adenocarcinoma (17) · Colorectal Neoplasms (15) · Esophageal Squamous Cell Carcinoma (14) · Neoplasm Metastasis (14) · Carcinoma, Hepatocellular (12) · Pancreatic Neoplasms (12) · Neoplasms (11) · Carcinoma, Renal Cell (10) · Gastrointestinal Neoplasms (10) · Melanoma (9)
Neoplasms (156) · Neoplasms by Site (152) · Digestive System Diseases (146) · Digestive System Neoplasms (144) · Gastrointestinal Diseases (132) · Gastrointestinal Neoplasms (122) · Stomach Diseases (99) · Neoplasms by Histologic Type (67) · Neoplasms, Glandular and Epithelial (64) · Carcinoma (62) · Head and Neck Neoplasms (47) · Esophageal Diseases (39) · Carcinoma, Squamous Cell (28) · Adenocarcinoma (27) · Respiratory Tract Neoplasms (26)
Oxaliplatin (50) · Capecitabine (35) · Fluorouracil (32) · pembrolizumab (30) · Docetaxel (23) · Leucovorin (20) · Paclitaxel (19) · Ramucirumab (17) · S 1 (combination) (16) · Cisplatin (15) · Nivolumab (15) · Irinotecan (11) · Surgical Procedures, Operative (10) · Drug Therapy (8) · Trastuzumab (8)
M.D. Anderson Cancer Center (8) · Eli Lilly and Company (6) · Fujian Cancer Hospital (5) · Gilead Sciences (5) · National Cancer Institute (NCI) (5) · Peking University (5) · Samsung Medical Center (5) · Shanghai Zhongshan Hospital (5) · The First Affiliated Hospital with Nanjing Medical University (4) · Tianjin Medical University Cancer Institute and Hospital (4) · University of Chicago (4) · Akeso (3) · Bezmialem Vakif University (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (3) · City of Hope Medical Center (3)
United States (104) · China (82) · France (25) · South Korea (23) · Germany (17) · Japan (16) · Spain (16) · United Kingdom (16) · Italy (15) · Australia (11) · Turkey (Türkiye) (10) · Belgium (8) · Canada (8) · Taiwan (8) · Poland (6)
Kohei Shitara, MD (3) · Andrew Blakely, M.D. (2) · Brian D Badgwell (2) · Farshid Dayyani, MD, PhD (2) · Hao Xu (2) · Kiran Turaga, MD (2) · Manish Shah, MD (2) · Matthew H Katz (2) · Rongbo Lin (2)
PMID 33792646, PMID 37037952, PMID 40117530, PMID 30982686, PMID 35101941, PMID 35623069, PMID 16822992, PMID 20728210, PMID 21444866, PMID 22645475, PMID 22797858, PMID 23430266, PMID 24628950, PMID 24943493, PMID 25915780, PMID 25944802, PMID 26106073, PMID 26541586, PMID 26857702, PMID 27324991, PMID 28291390, PMID 28548889, PMID 28558150, PMID 28679770, PMID 28760152, PMID 29168107, PMID 29543932, PMID 29853658, PMID 29880231, PMID 30786188, PMID 30911859, PMID 31189049, PMID 31236579, PMID 31239311, PMID 31301962, PMID 31302344, PMID 31765987, PMID 32058557, PMID 32346484, PMID 32556731, PMID 32880601, PMID 32946924, PMID 33068794, PMID 33492986, PMID 33494793, PMID 33613701, PMID 33741442, PMID 33986123, PMID 34363528, PMID 34468869
2014 (4), 2015 (3), 2018 (2), 2023 (2), 2025 (2), P30CA014599 (2), U10CA180820 (2), 2016 (1), P30CA008748 (1), P30CA014089 (1), P30CA016056 (1), P30CA016672 (1), P30CA072720 (1), U10CA180821 (1)